期刊
CANCERS
卷 14, 期 18, 页码 -出版社
MDPI
DOI: 10.3390/cancers14184473
关键词
hepatocellular carcinoma; influencing factors; changing epidemiology; Asia
类别
资金
- National Key R&D Program of China [2019YFA0709300]
- National Natural Science Foundation of China [U19A2008, 81972307, 82102705]
- China Postdoctoral Science Foundation [2020M671911, 2020TQ0313]
- Natural Science Foundation of Anhui Province [2008085QH376]
The incidence and mortality of hepatocellular carcinoma (HCC) in Asia are among the highest in the world. Understanding the epidemiological trends and risk factors of HCC is crucial for implementing measures to reduce the incidence in Asia.
Simple Summary The incidence and mortality of hepatocellular carcinoma (HCC) in Asia are among the world leaders. By understanding the changes in prevalence and influencing factors of HCC, we can better understand the current situation in Asia and take measures to reduce the incidence. Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, with high morbidity and mortality, and the incidence is on the rise. HCC imposes a heavy healthcare burden on Asian countries due to the presence of multiple HCC risk factors in this area. Chronic hepatitis B virus (HBV) infection, chronic hepatitis C virus (HCV) infection, non-alcoholic liver disease (NAFLD), aflatoxin and alcohol intake are the causes of HCC that cannot be ignored. Compared with the pre-vaccination era, universal vaccination of newborns reduces the incidence of HCC. Anti-viral therapy with nucleos(t)ide analogues also causes a decline in HCC incidence. Early screening and direct-acting antiviral agent are beneficial to the prevention and treatment of HCV. For HCC caused by NAFLD and other reasons, lifestyle changes are imperative. This paper introduces the epidemiological trends of HCC in Asia and highlight future efforts. Focusing on prevention may be the most effective way to improve the prognosis of this hard-to-treat cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据